This document provides guidance to manufacturers on the minimum requirements for the lifecyclemanagement of in vitro diagnostic (IVD) medical devices that are developed in preparation for and inresponse to a public health emergency involving infectious agents requiring immediate availability ofauthorized IVD devices.
NOTE: This document does not replace existing national (or regional) regulatory pathway requirements for IVD medical devices under non-emergency situations. The regulatory authorization process of emergency use-IVD medical devices is country-specific and it includes:
— following a risk management process; — monitoring the device’s post-market performance and quality assurance; — implementing a communication system.
Product Details
Published:
11/30/2024
ISBN(s):
9780539245929
Number of Pages:
22
File Size:
1 file , 1.5 MB
Note:
This product is restricted and cannot be purchased in the following countries Ukraine, Russia, Belarus